ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Domenico Mazzitelli
Klaus Holper
Fritz Sebening
Hans Meisner
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Günther, T.
Right arrow Articles by Meisner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Günther, T.
Right arrow Articles by Meisner, H.

Ann Thorac Surg 1998;65:754-760
© 1998 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Long-Term Results After Repair of Complete Atrioventricular Septal Defects: Analysis of Risk Factors

Thomas Günther, MD, Domenico Mazzitelli, MD, Christoph J. Haehnel, MD, Klaus Holper, MD, Fritz Sebening, MD, Hans Meisner, MD

Department of Cardiovascular Surgery, German Heart Center, Munich, Germany

Dr Günther, Department of Cardiovascular Surgery, German Heart Center Munich, Lazarettstraße 36, 80636 Munich, Germany.

Presented at the Thirty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Feb 3–5, 1997.


    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Background. We analyzed data from 320 patients to evaluate the impact of different preoperative, operative, and postoperative factors on the outcome after repair of complete atrioventricular septal defect.

Methods. Between October 1974 and December 1995, 320 patients with complete atrioventricular septal defect not associated with major cardiac anomalies were operated on. Two hundred seventy-four patients underwent total repair. Sixty-three patients (23%) were less than 6 months old. One hundred ninety-eight (72.2%) underwent primary repair. Seventy-six patients (27.7%) had a previous palliative operation.

Results. Operative mortality in patients who underwent primary repair decreased from 17.6% (1974 to 1979) to 5.0% (1990 to 1995) despite an increase in the number of patients younger than 6 months. In patients undergoing a two-stage procedure operative mortality was 3.9% (late mortality, 7.9%). Young age (<6 months) was an incremental risk factor (p = 0.008) for operative mortality in the early study period. Coarctation of the aorta (p = 0.02) and severe dysplastic left atrioventricular valve (p = 0.001) were associated with a higher risk for operative mortality. Freedom from reoperation at 10 years was 82.5% ± 3.8%.

Conclusions. In patients with complete atrioventricular septal defect, primary repair is the treatment of choice and can be accomplished with good results. In our experience over a period of more than 20 years, earlier date of operation, young age (<6 months), dysplastic left atrioventricular valve, and coexisting coarctation were incremental risk factors for hospital death. The presence of a previously placed pulmonary artery band did not alter the outcome of repair. The reconstructed atrioventricular valve shows a good and long-lasting performance.


    Introduction
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Many reports document improved surgical results after repair of complete atrioventricular septal defect (CAVSD) [1][2][3][4][5][6][7]. Some authors advocate primary repair at an age of 6 month or earlier [6][7]. Our retrospective analysis of 20 years’ experience examines various preoperative, operative, and postoperative risk factors that may have had an influence on the outcome after repair of CAVSD.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
We analyzed data from 320 patients with CAVSD operated on between October 1974 and December 1995 at the German Heart Center, Munich. Patients with major associated cardiovascular anomalies (tetralogy of Fallot, double-outlet right ventricle, transposition of the great arteries, total anomalous pulmonary venous drainage) were excluded. Two hundred seventy-four patients underwent repair of CAVSD: 167 (60.9%) were female and 107 (39.0%) male. One hundred eighty-four patients (67.1%) had Down’s syndrome. According to Rastelli’s classification [8], 67.9% (186 patients) presented type A, 3.6% (10 patients) type B, and 28.5% (78 patients) type C. Age at repair ranged between 1 month and 15.2 years (median, 0.9 years). Weight varied between 2.8 and 46.2 kg (median, 6.3 kg). Of the repairs, 56.6% (155 patients) were performed on infants less than 1 year old and 23% (63 patients) on infants less than 6 months old. Primary repair was our main target. As demonstrated in Fig 1, the number of patients who underwent primary repair at an age of less than 6 months increased constantly. One hundred ninety-eight patients (72.3%) had primary repair. One hundred forty-four (72.7%) of these were less than 1 year old. Seventy-six patients (27.7%) underwent a palliative operation 1 month to 11.9 years (median, 2.9 years) before repair, which included pulmonary artery banding in 51, pulmonary artery banding and patent ductus arteriosus ligation in 13, coarctation repair and pulmonary artery banding in 10, and patent ductus arteriosus ligation alone in 2. Thirty-five patients in this group (46%) had a previous palliative operation in another center. In our institution pulmonary artery banding was performed in patients with high pulmonary vascular resistance (>6 U/m2) not reactive to oxygen, hypoplastic left ventricle (left ventricular enddiastolic volume <50% of predicted normal), or coexisting coarctation. In a group of 46 patients a palliative operation was the only option because of severe pulmonary vascular disease. One hundred ninety-five patients presented additional minor cardiac anomalies (Table 1). Significant extracardial anomalies were observed in 9 patients, including Hirschsprungs’ disease, duodenal atresia/stenosis, congenital tracheal stenosis, and Apert’s syndrome. Thirteen patients presented mitral valve anomalies (double-orifice mitral valve, [n = 3], single left ventricular papillary muscle [n = 4], and dysplastic valve with extreme deficiency of mitral tissue [n = 6]).



View larger version (14K):
[in this window]
[in a new window]
 
The height of the columns indicates the percentage of patients older than 6 months (black columns) or younger than 6 months (white columns) undergoing primary repair in four consecutive time intervals, 1974 to 1995.

 

View this table:
[in this window]
[in a new window]
 
Incidence of Minor Cardiovascular Anomalies in 320 Patients With Complete Atrioventricular Septal Defect

 
All patients underwent at least one cardiac catheterization (Department of Pediatric Cardiology, Prof Dr K. Bühlmeyer), which included hemodynamic evaluation of systemic and pulmonary blood flow and resistance. The interval between angiocardiography and repair ranged between 1 day and 3.0 years (median, 2.7 months). Cardiac catheterization data are summarized in Table 2.


View this table:
[in this window]
[in a new window]
 
Preoperative Cardiac Catheterization Data1

 
Operative Method
One hundred sixty-four patients (59.8%) were operated on with hypothermic circulatory arrest (mean circulatory arrest time, 59.6 ± 8 minutes). Continuous extracorporeal circulation and moderate hypothermia (rectal temperature, 24° to 28°C) was established in the remaining patients. Mean total bypass time was 111.5 ± 30 minutes, and mean aortic cross-clamp time was 71.5 ± 16 minutes. Myocardial protection was provided in 95 patients using 4°C cold antegrade crystalloid cardioplegia (40 mL/kg; Bretschneider solution) [9].

In 23 patients (8.4%) (1974 to 1978), repair was performed using the one-patch technique described by Rastelli and associates [10]. Since 1978, adapting Carpentiers concept of the "tricommissure valve," we have applied the two-patch technique in 251 patients (91.6%) [11]. The ventricular septal defect was closed with a continuous 4.0 or 5.0 Prolene (Ethicon, Somerville, NJ) suture to affix a semicircular Dacron patch, keeping the suture line more on the right side of the crest of the ventricular septum. Then on the upper edge of the patch the valve leaflets were fixed with interrupted sutures starting at the central meeting point of the anterior and posterior leaflets. Competence of the reconstructed AV valve was tested with an injection of cold saline solution, and the anterior commissure or cleft of the left AV valve was closed using single Prolene stitches. In 12 patients the cleft was left open to prevent left AV valve stenosis. Usually we assess left AV valve diameter with a Hegar dilator, applying the nomograms of Rowlatt and colleagues [12].

A separate Dacron patch was then sutured to the superior aspect of the ventricular patch with the ventricular septal defect suture to close the atrial defect. In cases of sparse tissue in front of the coronary sinus the suture line passed above the AV node, placing the coronary sinus on the left side; otherwise, superficial stitches along the valve ring served for anchoring the atrial patch. Additional surgical procedures included closure of patent ductus arteriosus in 40 patients, debanding in 74 (followed by patch enlargement of the pulmonary artery in 11 patients and pulmonary artery resection with end-to-end anastomosis in 2 patients), ligation of left superior caval vein in 6 patients, resection of subaortic stenosis in 3, and closure of additional muscular ventricular septal defects in 2.

Data Acquisition
Complete patient data were assured by reviewing operative lists, computerized patient data bases, hospital records, and cardiac catheterization and echocardiographic reports. The majority of the patients underwent routine follow-up in our Department of Pediatric Cardiology, including physical examination, electrocardiography, radiography, and echocardiography. In 37 patients follow-up information was obtained by a telephone call to the patient’s family or physician or both.

Statistical Analysis
Univariate analysis was carried out using a t test or contingency tables to determine predictors of early and late mortality. Significant factors were entered into a multivariate logistic regression model to assess the independent impact of potential risk factors on early mortality. Actuarial survival curves were constructed using the Kaplan-Meier method. The log-rank test was used to ascertain differences between groups. A two-tailed p value of less than 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Preoperative Patient Data
Patients with Down’s syndrome showed a higher rate of type B (4.9% versus 1.1%) and C (31% versus 20%) CAVSD compared with patients without Down’s syndrome. This difference, however, was not significant (p = 0.17). There was also no difference in the incidence of minor associated cardiac anomalies in patients with or without Down’s syndrome (61.9% versus 62.9%). Five patients presented with advanced cardiorespiratory instability and required preoperative ventilatory assistance.

Catheterization Data
Preoperative cardiac catheterization data of all patients who underwent CAVSD repair were analyzed. The pulmonary-to-systemic flow ratio ranged between 0.3 and 11.0 (mean, 2.8 ± 2.0). Thirty-six patients had a pulmonary-to-systemic flow ratio of 4 or more. Room air pulmonary-to-systemic resistance ratio ranged between 0.01 and 2.56 (mean, 0.37 ± 0.35). In 60 patients the pulmonary-to-systemic resistance ratio was greater than 0.4. The average peak pulmonary systolic pressure in patients undergoing primary repair was 70 ± 14.53 mm Hg compared with 40.8 ± 20.36 mm Hg in those patients with a previous palliative operation (p = 0.001). Mean pulmonary-to-systemic flow ratio before primary repair was 3.0 ± 1.95 compared with 1.75 ± 1.75 (p = 0.001). Generally patients who had a palliative operation showed a higher pulmonary vascular resistance index and pulmonary-to-systemic resistance ratio values compared with those who underwent repair (pulmonary vascular resistance index, 6.1 ± 3.95 versus 4.5 ± 3.39 U/m2; pulmonary-to-systemic resistance ratio, 0.48 ± 0.38 versus 0.37 ± 0.35).

Mortality Data
Operative mortality of 274 patients who underwent repair was 6.6% (18 patients) There were 34 late deaths (12.4%), mainly caused by progressive cardiac failure and late pulmonary infections. The causes of death are summarized in Table 3.


View this table:
[in this window]
[in a new window]
 
Causes of Death After Repair of Complete Atrioventricular Septal Defect (52 deaths among 274 patients)

 
Of 198 patients who underwent primary correction, 15 (7.6%) died early and 28 (14.1%) late. Analysis of operative mortality in four consecutive time periods revealed a decrease from 17.6% (1974 to 1979) to 10.9% (1980 to 1984), 5.3% (1985 to 1989), and 5.0% (1990 to 1995) despite an increase in the number of patients having primary correction while younger than 6 months. In patients having primary correction while younger than 6 months, operative mortality was 18.2% compared with 3.4% in the age group of 6 to 12 months and 5.6% in older patients. In patients undergoing a two-stage procedure operative mortality was 3.9% (late mortality, 7.9%)

Incidence of Reoperation
Within an observation period of more than 20 years, 31 patients (11.3%) required 35 reoperations 7 days to 8.0 years (mean, 1.2 ± 2.0 years) after repair. Half of these patients underwent reoperation within 2 months after repair. Freedom from reoperation at 10 and 20 years was 82.5% ± 3.8% and 50% ± 16%, respectively (Fig 2). The indication for reoperation was significant left AV valve incompetence in 88.5% (31/35 reoperations). Refixation and repair of the left AV valve was possible in 87% (27/31 patients); it was not possible in 4 patients who required valve replacement. A mechanical prosthesis (size, 19 to 22 mm) was used in 3 patients; 1 patient received a biological prosthesis. Other indications for reoperation were subaortic stenosis in 4/35 (11.4%), recurrent ventricular septal defect in 13/35 (37.1%), and tricuspid valve incompetence in 5/35 (14.3%). Of the patients having reoperation, 64.5% (20/31) had undergone primary repair and 35.5% (11/31) had a two-stage procedure. Fourteen (45.1%) were less than 1 year old at the time of repair. Eight patients died (operative mortality, 16.1% [5/31]). Analysis of potential risk factors that may be associated with a higher reoperation rate showed no influence of weight less than 5 kg (p = 0.09) or age less than 6 months (p = 0.13). Rastelli type C CAVSD was more prevalent in patients having reoperation (42% versus 25.5%). This difference, however, was not significant (p = 0.29). Operative technique (one-patch versus two-patch technique) also showed no significant influence (p = 0.50). Incision of anterior or posterior bridging leaflets had no significant influence on reoperation rate (p = 0.77). Sixteen patients required a permanent pacemaker system, in 2 because of congenital heart block. Of the remaining 14 patients (5.1%), 10 needed a pacemaker system immediate postoperatively whereas 4 needed one 5.2 ± 3.73 years later.



View larger version (12K):
[in this window]
[in a new window]
 
Kaplan-Meier estimate of freedom from reoperation after repair of complete atrioventricular septal defect, with 70% confidence intervals. Freedom from reoperation at 10 and 20 years is 82.5% ± 3.8% and 50% ± 16%, respectively.

 
Follow-up
Follow-up data of 204 of 222 late survivors are available. The observation time ranged between 1 year and 21.5 years (mean, 7.2 years; total follow-up, 1,593 patient-years). Actuarial survival rate after 20 years is 79% ± 2.8% (Fig 3). One hundred ninety-three patients (87%) are in New York Heart Association class I, 81.5% (181 patients) do not need any medication, and 90.5% have sinus rhythm. Repeated echocardiographic evaluation of left AV valve function in 155 patients (70% of late survivors) revealed mild valve incompetence in 58% (90/155), moderate in 35.5% (55/155), and severe in 6.5% (10/155).



View larger version (11K):
[in this window]
[in a new window]
 
Kaplan-Meier estimate of survival function and 70% confidence intervals for 274 patients undergoing repair of complete atrioventricular septal defect. The actuarial survival at 20 years is 79% ± 2.8%.

 
Predictors of Mortality
Among the 274 patients who underwent repair, 18 (6.6%) died in the hospital. Mortality was determined by the date of surgical repair (p = 0.04). Analysis of potential risk factors associated with mortality (Table 4) showed that young age at repair (<6 month) (p = 0.008) was an incremental risk factor. Patients younger than 6 months and weighing less than 5 kg needed longer ventilatory assistance (mean, 8.4 ± 12.3 days) compared with those weighing more than 5 kg (mean, 3.3 ± 4.3 days) (p = 0.001) and a longer intensive care unit stay (12.2 ± 12.9 days versus 7.3 ± 8.8 days) (p = 0.004). Coarctation of the aorta (p = 0.02) and severe dysplastic left AV valve (p = 0.001) were associated with a higher risk for operative mortality. None of the patients with double-orifice mitral valve or singular papillary muscle died. Operative mortality correlated with preoperative pulmonary-to-systemic resistance ratio greater than 0.4 but failed to reach significance (p = 0.35). In 1978 operative technique shifted from the one-patch technique to the two-patch technique. Analysis of different operative techniques showed a trend toward better results in the two-patch group, but the difference failed to reach significance (p = 0.06). There was no significant difference (p = 0.28) in operative mortality of patients undergoing primary repair compared with those with a previous palliative operation. Comparison of preoperative catheterization data between the two groups showed a significant lower pulmonary artery pressure (p = 0.001) and pulmonary-to-systemic flow ratio and (p = 0.001) in the patient group with previous pulmonary artery banding. Mean weight at repair in the two-stage group was 13.6 kg versus 6.4 kg in primarily corrected patients.


View this table:
[in this window]
[in a new window]
 
Analysis of Potential Risk Factors Associated With Operative Mortality

 

    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
In this study the data of 320 patients with CAVSDs who were operated on within a period of more than 20 years were analyzed. To focus on "isolated" CAVSD, we excluded patients with associated major cardiac anomalies because patients with complex defects are known to carry a higher risk and require different surgical strategies [5][13][14]. Many reports describe improved surgical results after CAVSD repair [1][2][3][4][5][6][7], even though hospital mortality after primary repair varies between 2.5% and 10% [1][2][5][6][7]. Most early deaths are due to acute cardiac failure or failure of left AV valve repair [4][5]. Improved surgical technique and increasing experience in diagnostic as well as intraoperative and postoperative management are possible reasons for better results. Controversy, however, still exists regarding operative technique (one-patch versus two-patch technique), timing of operation, and operative strategy (primary repair versus two-stage procedure). The one-patch technique has proved to be satisfactory, as demonstrated in a number of publications [10][15][16][17][18][19]. Williams and associates [15], for example, applied the one-patch method for CAVSD repair in 32 children without early death. We used this technique between 1974 and 1978, and the hospital mortality was 17.7%. We discontinued using this technique because of frequent dehiscence of the suture line of the valve. Since 1978 the two-patch repair has been our method of choice. Analysis of different operative techniques showed a trend toward better results in the two-patch group, but the difference failed to reach significance (p = 0.06).

Concerning the time and mode of operation, primary repair of CAVSD is the treatment of choice today [2][6][7]. Most authors advocate primary repair in infants less than 1 year or even 6 months of age [3][6][7][17][18][19]. Yasui and associates [7] analyzed 40 patients (23 within the first year of life) and reported a 2.5% hospital mortality rate. As in other studies, the number of patients in our study group who underwent repair at an age of less than 1 year constantly increased over the years, with a simultaneous reduction in mortality [1]. Timing of operation is an important factor, to ensure surgical repair can be carried out before development of irreversible pulmonary vascular changes [7][19][20][21]. Pulmonary vascular disease in CAVSD develops during the first year of life; intimal fibrosis of the pulmonary vasculature can be found already at the age of 6 months [20]. Another argument in favor of repair in early infancy is the possible increase in degenerative changes of the AV valve as age increases [7]. Studer and colleagues [5] stated that young age was an incremental risk factor in the early period of their study (1967 to 1976) but disappeared as a risk factor after 1976. Pozzi and associates [3] and Berger and coworkers [22] found no correlation between age and mortality. In our series, age less than 6 months correlated with operative mortality. When different time periods were analyzed, however, young age was of borderline significance (p = 0.05) after 1984. This indicates that young age was an important risk factor in the early study period. Left ventricular hypoplasia, additional AV valve anomalies (eg, double-orifice mitral valve or singular papillary muscle) are also known as risk factors for increased mortality [2][5][21][23]. In contrast to these studies, none of our patients with double-orifice mitral valve or singular left papillary muscle died. In our experience, the presence of a severe dysplastic left AV valve was associated with a higher risk of operative mortality.

Despite a policy toward primary repair in young infants, we have a subgroup of 76 patients who underwent a two-stage procedure, with pulmonary artery banding in average 3.5 years before repair. We consider a hypoplastic left ventricle, elevated pulmonary vascular resistance (>6 U/m2 not reactive to oxygen test), severe dysplastic left AV valve, and coexisting coarctation as an indication for a palliative operation. Early experiences with pulmonary artery banding in CAVSD have demonstrated significant hemodynamic improvement. Thus Newfeld and associates [20] reported a reduction in pulmonary artery pressure, diminution of left-to-right-shunting, and prevention of progressive increases in pulmonary vascular resistance. Operative mortality, however, in collected series between 1961 and 1977 averaged 34% [22]. Comparing the operative mortality of our patients who underwent a two-stage or primary repair, we found no significant difference (p = 0.28). This coincides with the data published by Clapp and associates [21]. Tweddell and colleagues [1] report that none of their patients who underwent pulmonary artery banding died. In a subgroup of 46 patients we performed pulmonary artery banding only. Those patients generally came late, presenting advanced pulmonary vascular disease. Operative mortality in this group was 13%, with 11 late deaths (26%). The superiority of palliative operation followed by later repair versus primary repair as surgical therapy for these infants is not proven by this report. Valid arguments can still be made against a staged surgical approach. Survivors of banding still have an increased risk of death in the interval before subsequent repair. In our experience and also other centers, however, debanding does not represent a significant risk factor for correction [2][15][24]. We believe primary repair is the treatment of choice for patients with CAVSDs.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Tweddell JS, Litwin SB, Berger S, et al. Twenty-year experience with repair of complete atrioventricular septal defects. Ann Thorac Surg 1996;62:419-424.[Abstract/Free Full Text]
  2. Alexi-Meskishvili V, Ishino K, Dähnert I, et al. Correction of complete atrioventricular septal defects with the double-patch technique and cleft closure. Ann Thorac Surg 1996;62:519-525.[Abstract/Free Full Text]
  3. Pozzi M, Remig J, Fimmers R, Urban AE Atrioventricular septal defects: analysis of short- and medium-term results. J Thorac Cardiovasc Surg 1991;101:38-42.
  4. McGrath LB, Gonzalez-Lavin L Actuarial survival, freedom from reoperation, and other events after repair of atrioventricular septal defects. J Thorac Cardiovasc Surg 1987;94:582-590.[Abstract]
  5. Studer M, Blackstone EH, Kirklin JW, et al. Determinants of early and late results of repair of atrioventricular septal (canal) defects. J Thorac Cardiovasc Surg 1982;84:523-542.[Abstract]
  6. Thies WR, Breymann T, Matthies W, Crespo-Martinez E, Meyer H, Körfer R Primary repair of complete atrioventricular septal defect in infancy. Eur J Cardiothorac Surg 1991;5:571-574.[Abstract]
  7. Yasui H, Nakamura Y, Kado H, et al. Primary repair of complete atrioventricular canal: recommendation for early primary repair. J Cardiovasc Surg 1990;31:498-504.[Medline]
  8. Rastelli GC, Kirklin JW, Titus JL Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc 1966;41:296-308.[Medline]
  9. Bretschneider HJ, Huber G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg 1975;16:241-260.[Medline]
  10. Rastelli GC, Ongley PA, Kirklin JW, McGoon DC Surgical repair of the complete form of persistent common atrioventricular canal. J Thorac Cardiovasc Surg 1968;55:299-308.[Medline]
  11. Carpentier A Surgical anatomy and management of the mitral components of atrioventricular canal defects. In: Anderson RH, Shinebourne EA, eds. Paediatric cardiology. New York: Churchill Livingstone, 1978:477-490.
  12. Rowlatt JF, Rimaldi JMA, Lev M The quantitative anatomy of the normal child’s heart. Pediatr Clin North Am 1963;10:499.
  13. Pacifico AD, Ricchi A, Bargeron LM, Colvin EC, Kirklin JW, Kirklin JK Corrective repair of complete atrioventricular canal defects and major cardiac anomalies. Ann Thorac Surg 1988;46:645-651.[Abstract]
  14. Vogel M, Sauer U, Bühlmeyer K, Sebening F Atrioventricular septal defect complicated by right ventricular outflow tract obstruction. J Cardiovasc Surg 1989;30:34-39.[Medline]
  15. Williams WH, Guyton RA, Michalik RE, et al. Individualized surgical management of complete atrioventricular canal. J Thorac Cardiovasc Surg 1983;86:838-844.[Abstract]
  16. Abbruzzese PA, Livermore J, Sunderland CO, et al. Mitral repair in complete atrioventricular canal. J Thorac Cardiovasc Surg 1983;85:388-395.[Abstract]
  17. Metras D, Kreitmann B, Wernert F, et al. Correction du canal atrio-ventriculaire complet avant l’ àge d’un an. Arch Mal Coeur 1989;82:719-722.
  18. Santos A, Boucek M, Ruttenberg H, Veasy G, Orsmond G, McGough E Repair of atrioventricular septal defects in infancy. J Thorac Cardiovasc Surg 1986;91:505-510.[Abstract]
  19. Bender HW, Hammon JW, Hubbard SG, Muirhead J, Graham TP Repair of atrioventricular canal malformation in the first year of live. J Thorac Cardiovasc Surg 1982;84:515-522.[Abstract]
  20. Newfeld EA, Sher M, Paul MH, Nikaidoh H Pulmonary vascular disease in complete atrioventricular canal defect. Am J Cardiol 1977;39:721-726.[Medline]
  21. Clapp SK, Perry BL, Farooki ZQ, et al. Surgical and medical results of complete atrioventricular canal: a ten year review. Am J Cardiol 1987;59:454-458.[Medline]
  22. Berger TJ, Kirklin JW, Blackstone EH, Pacifico AD, Kouchoukos NT Primary repair of complete atrioventricular canal in patients less than 2 years old. Am J Cardiol 1978;41:906-913.[Medline]
  23. Chin AJ, Keane JF, Norwood WI, Castañeda AR Repair of complete common atrioventricular canal in infancy. J Thorac Cardiovasc Surg 1982;84:437-445.[Abstract]
  24. Silverman N, Levitsky S, Fisher E, Dubrow I, Hastreiter A, Scagliotti D Efficacy of pulmonary artery banding in infants with complete atrioventricular canal. Circulation 1983;68(Suppl 2):148-153.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. J.F. Hoohenkerk, A. C.G. Wenink, P. H. Schoof, D. R. Koolbergen, E. F. Bruggemans, M. Rijlaarsdam, and M. G. Hazekamp
Results of surgical repair of atrioventricular septal defect with double-orifice left atrioventricular valve
J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1167 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Stulak, H. M. Burkhart, J. A. Dearani, H. V. Schaff, F. Cetta, R. D. Barnes, and F. J. Puga
Reoperations After Initial Repair of Complete Atrioventricular Septal Defect.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1872 - 1878.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. H. Shuhaiber, S. Y. Ho, M. Rigby, and B. Sethia
Current options and outcomes for the management of atrioventricular septal defect
Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 891 - 900.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Dodge-Khatami, S. Herger, V. Rousson, M. Comber, W. Knirsch, U. Bauersfeld, and R. Pretre
Outcomes and reoperations after total correction of complete atrio-ventricular septal defect
Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 745 - 750.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Suzuki, E. L. Bove, E. J. Devaney, T. Ishizaka, C. S. Goldberg, J. C. Hirsch, and R. G. Ohye
Results of Definitive Repair of Complete Atrioventricular Septal Defect in Neonates and Infants
Ann. Thorac. Surg., August 1, 2008; 86(2): 596 - 602.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. P. Malhotra, F. Lacour-Gayet, M. B. Mitchell, D. R. Clarke, M. L. Dines, and D. N. Campbell
Reoperation for Left Atrioventricular Valve Regurgitation After Atrioventricular Septal Defect Repair
Ann. Thorac. Surg., July 1, 2008; 86(1): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. L. Backer, R. D. Stewart, F. Bailliard, A. M. Kelle, C. L. Webb, and C. Mavroudis
Complete Atrioventricular Canal: Comparison of Modified Single-Patch Technique With Two-Patch Technique
Ann. Thorac. Surg., December 1, 2007; 84(6): 2038 - 2046.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Lange, T. Guenther, R. Busch, J. Hess, and C. Schreiber
The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 304 - 310.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-Q. Lai, Y. Luo, C. Zhang, and Z.-G. Zhang
Utilization of Double-Orifice Valve Plasty in Correction of Atrioventricular Septal Defect
Ann. Thorac. Surg., April 1, 2006; 81(4): 1450 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Masuda, H. Kado, Y. Tanoue, K. Fukae, T. Onzuka, Y. Shiokawa, T. Shirota, and H. Yasui
Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life?
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 405 - 409.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Prifti, M. Bonacchi, M. Bernabei, A. Crucean, B. Murzi, F. Bartolozzi, V. S. Luisi, M. Leacche, N. S. Nathan, and V. Vanini
Repair of complete atrioventricular septal defects in patients weighing less than 5 kg
Ann. Thorac. Surg., May 1, 2004; 77(5): 1717 - 1726.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. S. Fortuna, D. A. Ashburn, N. Carias De Oliveira, H. M. Burkhart, I. E. Konstantinov, J. G. Coles, J. F. Smallhorn, W. G. Williams, and G. S. Van Arsdell
Atrioventricular septal defects: effect of bridging leaflet division on early valve function
Ann. Thorac. Surg., March 1, 2004; 77(3): 895 - 902.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. A. Al-Hay, S. J. MacNeill, M. Yacoub, D. F. Shore, and E. A. Shinebourne
Complete atrioventricular septal defect, Down syndrome, and surgical outcome: risk factors
Ann. Thorac. Surg., February 1, 2003; 75(2): 412 - 421.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Stellin, V.L. Vida, O. Milanesi, G. Rizzoli, M. Rubino, M.A. Padalino, R. Bonato, and D. Casarotto
Surgical treatment of complete A-V canal defects in children before 3 months of age
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 187 - 193.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Takayama, A. Sekiguchi, M. Chikada, M. Noma, A. Ishizawa, and S. Takamoto
Mortality of pulmonary artery banding in the current era: recent mortality of PA banding
Ann. Thorac. Surg., October 1, 2002; 74(4): 1219 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Boening, J. Scheewe, K. Heine, J. Hedderich, D. Regensburger, H.-H. Kramer, and J. Cremer
Long-term results after surgical correction of atrioventricular septal defects
Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 167 - 173.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nakano, H. Kado, Y.-i. Shiokawa, and K. Fukae
Surgical results of double-orifice left atrioventricular valve associated with atrioventricular septal defects
Ann. Thorac. Surg., January 1, 2002; 73(1): 69 - 75.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. Lange, C. Schreiber, T. Gunther, M. Wottke, F. Haas, F. Meisner, J. Hess, and K. Holper
Results of biventricular repair of congenital cardiac malformations: definitive corrective surgery?
Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1207 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. A. Crawford Jr and M. R. Stroud
Surgical repair of complete atrioventricular septal defect
Ann. Thorac. Surg., November 1, 2001; 72(5): 1621 - 1629.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Chikada, A. Sekiguchi, T. Miyamoto, M. Matsuzaki, R. Ishida, and A. Ishizawa
Direct closure of ostium primum defect in the repair of atrioventricular septal defect
Ann. Thorac. Surg., August 1, 2001; 72(2): 430 - 432.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C Wren and J J O'Sullivan
Survival with congenital heart disease and need for follow up in adult life
Heart, April 1, 2001; 85(4): 438 - 443.
[Abstract] [Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
A.J.J.C. Bogers, G.P. Akkersdijk, P.L. de Jong, A.H. Henrich, J.J.M. Takkenberg, R.T. van Domburg, and M. Witsenburg
Results of primary two-patch repair of complete atrioventricular septal defect
Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 473 - 479.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Wetter, N. Sinzobahamvya, C. Blaschczok, A.-M. Brecher, L. M. Gravinghoff, A. A. Schmaltz, and A. E. Urban
Closure of the zone of apposition at correction of complete atrioventricular septal defect improves outcome
Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 146 - 153.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Domenico Mazzitelli
Klaus Holper
Fritz Sebening
Hans Meisner
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Günther, T.
Right arrow Articles by Meisner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Günther, T.
Right arrow Articles by Meisner, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS